Dr. Remick has been principal investigator or co-investigator on tens of millions of dollars in externally funded cancer and AIDS research at Case Comprehensive Cancer Center, Cleveland. He is a graduate of New York Medical College, with residency training at Johns Hopkins and fellowship training at the University of Wisconsin Clinical Cancer Center.

Dr. Remick’s research focuses on early phase cancer therapeutics and AIDS malignancies. He has conducted and led numerous trials (from Phase I to Phase III studies) of antiretroviral agents and new cancer drugs, having received continuous NIH-funding for the past 15 years for the cooperative and collaborative development of a variety of these compounds and strategies. He has developed and continues to pursue the development of new anticancer agents in close collaboration with the NCI and other partners for both solid tumors and AIDS neoplasms. Recently completed phase I and II trials under his direction have included rebeccamycin analog, combretastatin A-4 phosphate the first vascular disrupting agent to enter the clinic and bryostatin.

In 1996, Dr. Andrès received his MD degree in Internal Medicine, at the University of Strasbourg, France. He worked as an associated professor in the University Hospital of Strasbourg, France. In 1998 he worked as PhD in Molecular Biology in the Laboratory of Professor Hoffmann (2011, Nobel Prize of Medicine) in the field of cationic antimicrobial peptides and pathogens - host relations. In 2002, he was nominated Professor at the University of Strasbourg, France.  He also was in the head of an Internal Medicine Department (of >60 beads) in the University hospital of Strasbourg, France. He was awarded the French Society of Haematology, price for research in the field of anaemia related to cobalamin or folate deficiencies in 2004. Achievements include development of research in: all type of anaemia, neutropenia and thrombocytopenia, particularly drug-induced neutropenia and agranulocytosis or thrombocytopenia; haematopoietic growth factors; and cobalamin deficiencies. His recent works also include research and development on human sounds analysis, electronic stethoscope, e-auscultation, and e-medicine. In that function he was recruited as advisor to several pharmaceutical companies or start-up. In 2007, He was nominated in the French National Commission of Pharmacovigilence.

Blood Transfusion Disorders

Prof. Shahzad is currently affiliated with University of Vienna, Austria. Prof. Shahzad is one of the pioneers, working for the progress of translational medicine field. He is serving as a secretary general and director of administration for “international society for translational medicine (ISTM)” He is serving as visiting professor of translational medicine, at the First Affiliated Hospital, Harbin Medical University, Harbin, China. He is also appointed as associate professor of translational medicine (Adj), at the First Affiliated Hospital, Wenzhou Medical College, China. Prof. Shahzad has won many prestigious international fellowships and awards. Prof. Shahzad is invited speaker for many international life sciences conferences.

Translational Research and Clinical Diagnostics

Dr. Daniel S. Smith is Professor and Director in the Department of Apheresis and Transfusion Medicine at Indiana University of Health, USA

Blood Transfusion Disorders

Dr. Steven L. Spitalnik did M.D. 1978, University of Chicago Research Fellowship, 1980-81 University of Rochester Research Fellowship, 1983-85 National Institutes of Health Residency, 1978-80 University of Rochester School of Medicine Residency.

Biochemistry, cell biology, and immunology of glycoproteins and glycolipids.

Prof. Han-Mou Tsai has received his M.D. from National Taiwan University College of Medicine during the period of 1972-1979. Currently, he is a Professor of Medicine and Pathology and holds the title of M. Elaine Eyster M.D. Professor of Hematology at Pennsylvania State University Milton S. Hershey College of Medicine. He has authored many research articles and is an author on the subject of thrombotic thrombocytopenic purpura and hemolytic uremic synrome in a major hematology textbook. He has served as a member of the editorial or advisory board of major hematology journals. He is a member of the American Society of Hematology and the International Society of Thrombosis and Hemostasis.

von Willebrand factor, ADAMTS13, Shear stress, Thrombotic thrombocytopenic purpura, Microvascular thrombosis.

Dr. Douglas Blackall attended medical school at the University of Arkansas for Medical Sciences and received his medical degree in 1988. He then completed residency training in Clinical Pathology and fellowship training in Blood Banking or Transfusion Medicine at the University of Pennsylvania. Currently, he is the Chief of Pediatric Pathology and the Medical Director of the Blood Bank and the Clinical Laboratories at Arkansas Children’s Hospital in Little Rock, AR. He is also a Professor of Pathology at the University of Arkansas for Medical Sciences. Dr. Blackall is the author of numerous publications focused mostly in the field of Transfusion Medicine.

Immunology of human blood group antigens and antibodies and clinical transfusion practice.

Dr. Charles A. Schiffer, head of the Malignant Hematology Multidisciplinary Team at the Barbara Ann Karmanos Cancer Center in Detroit recently received a prestigious 2010 Statesman Award at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. The Statesman Award presented to Dr. Schiffer recognizes the extraordinary dedication of ASCO members for their voluntary efforts that benefit the Society, the specialty of oncology, and, most importantly, the patients served. This award is given to volunteers who have given 20 or more cumulative years of service to the Society. Since becoming active with ASCO 35 years ago, Dr. Schiffer has chaired numerous committees and symposiums that further the work of the Society. He frequently has been requested to speak and share his expertise related to hematologic malignancy research, acute myeloid leukemia and lymphoma. He has authored and co-authored more than 290 articles and 75 book chapters on topics concerning the treatment of leukemia in adults, platelet transfusion and granulocyte transfusion therapy, among others. He earned his BA cum laude at Brandeis University and his M.D at New York University School of Medicine. He has served on the Editorial Boards for Blood, the Journal of Clinical Oncology, International Journal of Hematology and reviews articles for multiple journals. Dr. Schiffer is frequently named to Castle Connellys list of Top Doctors, Best Doctors in Americaand Hour Detroit Magazines Top Docs. Committee memberships have included Chairman of the Leukemia Committee of the Cancer and Leukemia Group B, Chairman of the Food and Drug Administration Oncologic Drug Advisory Committee, Medical Oncology Subspecialty Board of the American Board of Internal Medicine, and grant reviews for the National Cancer Institute and Leukemia Lymphoma Society of America. Dr. Schiffer is also a Professor of Medicine and Oncology at Karmanos and the Wayne State University School of Medicine. His work has been recognized by the College Teaching Award and the Best Teacher in Hematology - Fellows Award. In 2006, he received the Dr. John J. Kenney Award from the Leukemia Lymphoma Society of America and the Celgene Award for Career Achievement in Hematology. He was recently inducted into the Academy of Scholars of Wayne State University, the highest recognition accorded to academic faculty at the University.

Clinical Epigenetics, Hematology/Oncology, Leukemia and Myelodysplastic Sundrome

Dr. Chan is Medical director of the pediatric hematology oncology and stem cell transplantation program, Methodist Chidlren•s Hospital of South Texas, San Antonio. Clinical Professor of Pediatrics, University of Texas Health Science Center at San Antonio. Dr. Chan is the board-certified in Pediatric Hematology and Oncology Fellow of the Royal College of Physicians and Surgeons of Canada. He is a member of the American Society of Hematology, American Society for Blood and Marrow Transplantation, and Canadian Medical Association.

Cord blood transplantation, high-dose chemotherapy, supportive care, Stem cell transplanation for pediatric patients, Childhood leukemia, Pedaitric hematologic disorders.

Dr. Harold Ross Roberts has been working as a Professor of medicine & pathology, University of North Calorina, School of medicine, Chapel Hill, USA

Blood disorders, Transfusion medicine

Dr. William Ebomoyi was the Employee of the Month for November 2009. He was recognized for going beyond the call of duty in student advising during the 2009/2010 academic year. He is professor of health studies in the Chicago state university.

International Health, Primary Health Care Services, Program Planning and Evaluation, Genetic Epidemiology, Epidemiology of HIV/AIDS and other sexually transmitted infections, Ecological Aspects of Human Diseases, Nutritional Anthropometry, and Community Health Education, Student-Centered learning, Environmental Epidemiology and Health Disparities.

Kashuk is Professor of Surgery, Chief of the Section of Acute Care Surgery, and the Associate Chief of the Division of Trauma, Acute Care and Critical Care Surgery. He also serves as the Associate Director of the Shock Trauma Center. Prior to his arrival at Hershey, he served as an Associate Professor of Surgery at the University of Colorado and as a staff surgeon at Denver Health Medical Center’s Rocky Mountain Trauma Center. For nine years, he served as an officer in the Israeli Defense Forces, and developed special expertise in the care of traumatic bomb explosion injuries. Dr. Kashuk is the author and co-author of over 70 academic manuscripts as well as book chapters. Dr. Kashuk’s primary research interests are in post injury coagulation related disorders. He is a member of numerous professional societies, currently serving as the Vice Chair, Society of Critical Care Medicine’s Disaster Management course and committee, as well as the injury prevention committee of the American Association for Surgery of Trauma. Dr. Kashuk recieved his BA, cum laude, from Lawrence University, Appleton, Wisconsin, and his MD degree from the University of Minnesota, Minneapolis, Minnesota. Dr. Kashuk serves on the editorial board of Patient Safety in Surgery and as a reviewer for most major journals of surgery.

post injury coagulation related disorders

Dr. Lawrence G. Lum has received his M.D. from the University of California San Francisco and did his internship and Pediatric Residency at UCSF and the University of Colorado, Denver, CO. He did a Allergy Immunology fellowship in the metabolism Branch of DCT, NCI, NIH. He was awarded his honorary Doctor of Science from the University of Redlands, California in 2000. He is working as the Scientific Director of the BMT & Immunotherapy program, Professor of Medicine at the Barbara Ann Karmanos Cancer Institute and Wayne State University. He is also a Professor of Immunology and Microbiology at Wayne State University. He has served as a grants reviewer, manuscript reviewer, director of several immunotherapy programs and is currently in charge of the Research Program and cGMP Laboratory for the BMT & Immunotherapy program for Karmanos. Dr. Lum has published 150 articles and over 190 of abstracts and has been an invited lecturer 134 times. Currently, he is a member of Barbara Ann Karmanos Cancer Institute located in Detroit, Michigan, which is affiliated with Wayne State University, of the nation’s leading Urban Research Universities. He was a member of NCI Scientific Review and Evaluation Group for P01 on Immunotherapy for Cancer, and he was an Intramural NCI Site Visit Reviewer for NCI/NIH. Dr. Lum received the Alumni Centennial Award from University of Redlands in 2007.

Dr. Lum’s primary focus is enhancing the patient’s immune system to make it a better cancer-killing machine. Dr. Lum is developing different strategies/approaches to enhance the cancer killing function of T cells by manipulating the T cells of the patient’s immune system to boost anti-tumor immunity to decrease relapse rates in multiple myeloma and non-Hodgkin’s lymphomas.

Leo J McCarthy, M.D. an expert on the history of blood transfusion, and Professor Emeritus of Pathology and Laboratory Medicine, Medicine and Pediatrics continue research and lectures on transfusion. In 1991, Dr McCarthy became a Fellow in the Royal College of Physicians of Ireland, which was established in 1654, and in 1994 he became a fellow in the Royal College of Physicians of Edinburgh.

Dr. McCarthy created and endowed the Annual McCarthy Lecture in Transfusion Medicine in 1997 at the Indiana University School of Medicine, where he, also, established an accredited fellowship in Transfusion Medicine in collaboration with the Indiana Blood Centre. At the 1997 Indiana Association of Blood Banks he received the Victor H. Muller Award to acknowledge his contributions to transfusion medicine, blood banking and transfusion services.

In 2000 he became an alumnus member of the Alpha Omega Alpha (AOA) Medical Honor Society Nebraska Chapter. He was honoured in 2001 with the IUPUI campus-wide Glenn W. Irwin, JR., M.D. Excellence Recognition Award.

In 2002 he received John Elliot Memorial Award that recognizes an individual for outstanding service to the American Association of Blood Banks, an international, not-for-profit association dedicated to the advancement of science and the practice of transfusion medicine. One year later in recognition of his mastery of and passion for transfusion medicine, he became a Sagamore of the Wabash, Indiana’s highest awarded by the Governor.

Dr. McCarthy, the formerly director of Transfusion Medicine for Indiana University School of Medicine for three decades, now produces scholarly works on the history of transfusion. Dr. McCarthy has created two unique, graphic visions of blood transfusion throughout history. The Timeline of the History of Transfusion and the Indiana University School of Medicine Library are pleased to present this original graphic of the time line on the history of transfusion.

History of blood transfusion, Medicine and Pediatrics.

Yi-Xian Qin is a Professor in the Department of Biomedical Engineering (BME) at Stony Brook University. He received his Ph.D. in Mechanical Engineering (specializing in Biomechanics) from The State University of New York at Stony Brook in 1997. After a short postdoctoral training in Musculoskeletal Tissue Growth and Regeneration at Orthopaedics of Stony Brook, he became one of the founding faculty members in the Department of BME at Stony Brook University in 1998. His primary scholarly contributions to the field gravitate towards improving the understanding of the physical milieu of the skeletal system under physical regulations, particularly how fluid flow serves as regulatory signals to the bone cell functions and tissue remodeling. His research interest is also focused on the diagnostic and therapeutic ultrasound for characterization the physical properties of bone and guided treatment for bone diseases. These works may potentially impact to the health and well-being of the (ever) aging population, as it pertains directly to understanding the etiology of osteoporosis, and may well identify novel means of suppressing bone loss, and may provide a unique clinical assay to accelerate healing and regeneration via non-pharmaceutical approaches. He has been an active member for more than 15 national and international scientific societies, and is serving as an editorial member of several reputed journals like BMC Journal of Orthopaedic Surgery and Research. He served as organizer for several national and international conferences, i.e., Orthopedic and Rehabilitation Engineering track chair for BMES, the International Bone Fluid Flow Workshop, and the International Conference on Osteoporosis and Bone Research. He has authored more than 70 papers and book chapters in related field.

Bone blood flow and remodeling, Mechanotransduction in biological tissues, Fluid flow and bone health, Tissue engineering and regeneration

Dr. Zhizhuang has been working as a Professor & Director of pathology in University of Oklahoma Health Sciences.

Tyrosine Kinase JAK2 and Myeloproliferative Disorders, pathological role of a mutant form of tyrosine kinase JAK2 in myeloproliferative disorders by using transgenic animal model.

Dr. Vincent is Professor of intensive care at the Université Libre de Bruxelles and Head of the Department of Intensive Care at the Erasme University Hospital in Brussels. He has authored or co-authored more than 750 peer-reviewed publications, about 90 books and more than 800 original abstracts. He is the editor-in-chief of "Critical Care", "Current Opinion in Critical Care", and "ICU Management" and member of the Editorial Boards of more than 30 journals including "Critical Care Medicine" (senior editor), "PLoS Medicine", "Lancet Infectious Diseases", “Anesthesiology”, "Intensive Care Medicine", "Chest", "Shock", and "Journal of Critical Care". He is presently Secretary General of the World Federation of Societies of Intensive and Critical Care Medicine (WFSICCM), a Past-President of the European Society of Intensive Care Medicine (ESICM), the European Shock Society (ESS), and Past-Chair of the International Sepsis Forum (ISF). He received the Distinguished Investigator award of the Society of Critical Care Medicine, the College Medalist Award of the American College of Chest Physicians, he was the Recipient of the "Society Medal”(lifetime award) of the European Society of Intensive Care Medicine and he received the prestigious Belgian scientific award of the FRS-FNRS (Prix Scientifique Joseph Maisin-Sciences biomédicales cliniques).

Anemia and transfusion in the acutely ill

Hemodynamic alterations in the acutely ill

Ulrich Mahlknecht is Director of the José Carreras Research Center for Immunotherapy and Gene Therapy, Saarland University Medical School, Dept. of Internal Medicine. Director, Molecular Medicine Competence Center (KoMM), Saarland University President of the “Clinical Epigenetics Society (ClEpSo)” Full Professor of Internal Medicine, Saarland University Medical Center since 2007 Associate Professor of Internal Medicine, University of Heidelberg Medical Center, Dept. of Hematology/Oncology Assistant Professor at the Johann Wolfgang Goethe University of Frankfurt Medical Center. He has received his PhD from the State University of New York in Molecular Medicine, 1996-1999. He has received his MD degree from the University of Tübingen in Germany in 1995 Joachim Kuhlmann AIDS-Award (2001). Graduate Stipend of the Novartis Foundation for therapeutic research (2001). He received Clinical Science Award 2004 of the German Society for Immunotherapy. He is serving as Editor-in-Chief or as an editorial board member of 5 journals and reviewer of 20 journals.

Clinical Epigenetics, Hematology/Oncology, Leukemia and Myelodysplastic Syndromes.

I was born in Desfina, Greece, on 1946. MD Athens University Medical School 1970. University assistant 1978-1981, Senior Registrar 1981-1983, Senior Lecturer 1983-1988. Diplomate Greek Board of Medicine 1978 and of the Greek Board of Hematology 1981, Ph.D. in 1981. From 1984-1987 in France Univerite Paris VII University Assistant of Ecole de Medicine Lariboisier-Saint Louis. Assistant Professor 1989-1995, Associate Professor 1995-2009. 2010 Professor of Internal Medicine and Hematology, 2011 Head Hematology Department and Bone Marrow Transplantation Unit of Athens University School of Medicine. Book publications: The Red Cell Hemoglobin Content of Embryos from Parents with β-thalassemia: (1981); Veino-Occlusive Liver Disease (1985); Bone Marrow Transplantation in SAA (1989); Side Effects in Hematological Patients (1994); CD-ROM Atlas of Hematology (1996); CD-ROM Hematology – Diagnostic Approach (1998); The Routine "Blood Count" (1998); Aplastic Anemia (1998); From Hematological Symptoms to Diagnosis (7th Edition 2009); Atlas of Hematology (3rd edition 2009); Disorders of WBC number (2005); Atlas of Hematology, English Edition (3rd edition 2009 ); Eosinophilia (2008). Atlas of Hematology (LeukemiaNet EU-WP10 Project 2009). To date, I have published over 550 works in Greek, English and French, including book publications. Εditor-in-Chief of Haema (Hellenic Hematology Society), Assoc. Editor of Hippokrates, Athens Medical School Journal; the hematology section Εditor of Archives of Hellenic Medicine, Athens Medical Society Journal; Associate Editor BMC Blood Disorders, Internet Journal of Hematology and Editorial Board in many International and National Medical Journals. President of National Committee and Member of the International Committee of Index Copernicus and Member of the Morphology Faculty Leukemianet Morphology Project and Member of the Second Morphology Consensus Study I of the European Morphology Faculty for harmonizing cell terms. I have received five First Prizes Awards for best work in hematology (National and European).

Aplastic anemia, paroxysmal nocturnal hemoglobinuria, bone marrow transplantation, acute leukemias

B.S. UC Davis. Biological Sciences. 1985, M.D. University of Cincinnati. 2004, Residency Clinical Pathology. 1998. Board Certified, Residency Internal Medicine. 2000. Board Certified Fellowship Hematopathology. 2001. Board Certified Fellowship Transfusion Medicine. 2005. Board Certified, Faculty UC Davis Department of Pathology. 2005-Present

Dr. Dwyre has clinical responsibilities in hematopathology, including leukemia, lymphoma and flow cytometry, as well as apheresis (the withdrawal of blood from a donors body, removal of one or more components, and transfusion of the remaining blood back into the donor), which includes pediatric apheresis and progenitor-cell collection. He is involved in hematology-related clinical research involving leukemia, lymphoma and apheresis.

Beth Huizenga Shaz is Chief Medical Officer of New York Blood Center and adjunct professor in the Center for Transfusion and Cellular Therapy, Department of Pathology and Laboratory Medicine, Emory University School of Medicine. She received her BS in chemical engineering from Cornell University MD from the University of Michigan Medical School. She completed a surgical internship at Georgetown University, anatomic and clinical pathology residency at Beth Israel Deaconess Medical Center, Harvard Medical School, and blood banking transfusion medicine fellowship in the Joint Program in Transfusion Medicine, Harvard Medical School. She serves as an associate editor of Transfusion and is on the editorial board of the Journal of Clinical Apheresis. She has published over 30 articles and co-edited two textbooks.

Transfusion Medicine

Juan C. Duchesne is a Director of Tulane Surgical Intensive Care Unit, Tulane School of Medicine, New Orleans Louisiana Associate Professor of Critical Care Surgery Trauma and Anesthesia, Tulane & LSU Department of Surgery and Anesthesiology Medical Director Trauma Telemedicine Spirit of Charity Trauma Center, New Orleans Louisiana Medical Advisor For Louisiana Emergency Response Network ATLS Louisiana State Faculty. He has completed his B.A in Biology in University of Puerto Rico (1995). He has completed his MD in Ponce School of Medicine (1999). He has completed his General Surgery Residency, LSUHSC New Orleans Louisiana (2004). He has completed his Trauma and Critical Care Surgery Fellowship, LSUHSC New Orleans Louisiana (2005). He received Outstanding Leadership Award from Eastern Organization of Surgical Trauma (2009). He is serving as an editorial board member of reputed journals and reviewer of 10 journals. Involved in Military, Disaster Management, Rural Trauma and Injury Prevention EAST Committees.

Damage Control Surgery, Damage Control Resuscitation with Close Ratio Resuscitation for PRBC to Plasma, Low Volume Resuscitation in Severely injured patients, Trauma in Obese patients, Impact of Telemedicine in Trauma Comunications.

Henry E. Rice, MD, is the Paul H. Sherman Associate Professor and Chief, Division of Pediatric Surgery. Duke University Medical Center. He received his medical degree from Yale University in 1988, and received his training in general surgery and pediatric surgery at the University of Washington, University of California, San Francisco, and the Children´s Hospital of Buffalo. He served as editorial reviewer for several leading pediatric and pediatric surgery journals.

Pediatric surgery, with particular focus on the role of partial splenectomy for treatment of congential hemolytic anemias as well as the surgical management of children undergoing stem cell transplantation.

Dr. Kenneth Isimemen Ataga had been working as an Associate Professor, Division of Haematology- Oncology at University of North Calorina.

Haematology and Oncology

I am a native of Hawaii which is still considered “home”. Although my interest in oncology began while I was a resident at UCSD, substantial learning occurred during the three years I was at Duke University Medical Center. A member of the faculty at WVU since July 1989, I have continued to grow academically, professionally, and most of all, personally.

Understanding cancer at the molecular level

Dr. Hamadanihas been working as an Assitant Professor of medicine in the secssion of hematology and oncology in the west virgenia university.

Hematology and oncology.

Dr. Cabrales is an Assistant Professor, Department of Bioengineering, University of California San Diego, La Jolla, CA. He has received a PhD in Engineering from the University of Los Andes, Bogota Colombia in 2004. He has completed his B.S and M.S. in Mechanical Engineering in the University of Los Andes, Bogota Colombia in 1998 and 2000, respectively. He received several Young Investigator Awards from American Society for Artificial Internal Organs, Blood Substitutes Society and Microcirculation Society. He has served as invited editor of Antioxidant Redox Signaling, and is currently a reviewer for more than12 journals. He has published more than 86 peer-review articles and 6 book chapters.

Non invasive instrumentation, Microvascular regulatory mechanism, Oxygen carrier blood substitutes, Hemoglobin based blood substitutes, Tissue oxygenation and oxygen regulation, Plasma expander, Coagulation cascade, microscopy, model design for microvascular studies, Nitric oxide regulation and gas transport.

Dr. Domenico has been working as an Assistant Professor in the Department of Cardiothoracic Surgery at University of Iowa

Transfusion Medicine

Carmen Jane Booth is Assistant Professor of Comparative Medicine; Co-director, Mouse Phenotyping Service. She did her B.S., University of California at Davis, 1987, D.V.M., University of California at Davis, 1992 and her Ph.D., University of Washington (Seattle), 2005

Pathology of genetically engineered mice; Pathology of inflammation; Pathology of aging; Veterinary Pathology; mouse pathology; phenotyping; Hemophilia in Rats

Dr. C-Y. Oliver Chen has received his PhD in human nutrition and exercise at Virginia Tech University during the period between 1996 and 2001. Currently, he is working as Assistant Professor and Research Scientist in Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University. He is serving as an editorial member of three journals like World Journal of Clinical Oncology, Recent Patents on Food, Nutrition & Agriculture, Open Longevity Science. He has authored 36 research articles and 8 reviews or book chapters. He is a member of American Society of Nutrition and American Chemical Society.

His research interests include bioavailability, metabolism, and bioactions of phytochemicals, their interaction with physical activity, and the implication of these relationships to health promotion and disease prevention during the aging process. He is also interested in the role of oxidative stress and nutrition programming in development of chronic diseases, including atherosclerosis, insulin resistance, and obesity.

Dr. Christopher A. Tormey is an Assistant Professor of Laboratory Medicine at the Yale University School of Medicine and an attending Clinical Pathologist at the VA Connecticut Healthcare System. Dr. Tormey received his undergraduate degree in Chemistry from the University of Chicago and his M.D. from New York Medical College. He subsequently completed residency training in Laboratory Medicine/Clinical Pathology and a fellowship in Blood Banking/Transfusion Medicine, both at the Yale School of Medicine. Dr. Tormey is also board-certified in each of these medical disciplines. In addition to his clinical work, Dr. Tormey has He has published over 25 scientific manuscripts and book chapters in the fields of Transfusion Medicine, Clinical Pathology, and Hematopathology and has served as an ad hoc reviewer for journals such as Blood, Transfusion, Journal of Clinical Apheresis, and Military Medicine.

Blood group alloimmunization, Platelet storage lesion, Coagulation/platelet function.

Elias Jabbour joined the University of Texas M. D. Anderson Cancer in 2003 as a fellow in the Department of Hematology/Leukemia and Stem cell. Thereafter, in 2007, he joined the faculty in the Leukemia department as Assistant Professor. Dr. Jabbour has taken an active role in the medical community, participating in numerous scientific meetings. He has authored or co-authored more than 100 medical publications and abstracts and serves as a reviewer numerous scientific journals. In 2005, 2006, and 2007, he received the ASCO and the ASH merit awards for Outstanding Clinical fellow.

Dr. Jabbour is actively involved in research in both acute and chronic forms of leukemia. He was actively involved in clinical trials that lead to the approval of several drugs in chronic myeloid leukemia (CML) and myelodysplastic syndromes. His research on resistance to imatinib and mutations of the protein kinase domain were presented in several international; meetings and published in peer-reviewed journals. He is also developing tailored therapies to CML.

Dr. Chang Qing Xia is Assistant Professor in Department of Pathology, Immunologyand Laboratory Medicine,University of Florida College of Medicine in 1999-1996 Ph.D. Institute of Hematology, Peking University Beijing, China. His MS in Institute of Hematology, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China in 1996-1993 and his MD Weifang Medical College, Weifang, China. 1988 to 1983

Hematology/Oncology

Shan Yuan is the Assistant Medical Director of Transfusion Medicine, at the Ronald Reagan UCLA Medical Center in Los Angeles, California. She is also an Assistant Professor of Department of Pathology and Laboratory Medicine, at the David Geffen School of Medicine at UCLA. Prior to joining UCLA, she was a physician at the City of Hope National Medical Center in Duarte, CA. She received fellowship training in transfusion medicine and blood banking at the Puget Sound Blood Center in Seattle, WA (2004-2005) she completed her training in clinical pathology at the University of Washington Medical Centre, in Seattle WA (2000-2004) and served as the Chief Resident. She received her M.D. degree from Duke University School of Medicine (1996-2000). She completed her B.A. in biology at Oberlin College, Oberlin, OH (1992-2000). She has received the Paul E. Strandjord Young Investigator Award twice from the Academy of Clinical Physicians and Scientists and the Strandjord-Clayson Research Award from the University of Washington Medical Centre. She has also served as the reviewer for a number of journals.

Adverse reactions in apheresis donors, Recruitment and retention of young donors, Immunohematology, Autoimmune hemolytic anemias.

Dr. Mei Sheng Duh is a Managing Principal of Analysis Group, Inc., Boston, Massachusetts. She is also a guest lecturer in the Department of Epidemiology at the Harvard School of Public Health and is an elected member to American Society of Hematology. Dr. Duh is a graduate of the Harvard School of Public Health, where she received a Doctor of Science degree with a concentration in Pharmaco-epidemiology, Biostatistics, and Health Policy and Management. She received a Masters’ degree in Public Health in the area of chronic disease epidemiology from Yale School of Medicine, and a B.S. in pharmacy from Taiwan. She is a pharmaco-epidemiologist, specializing in drug safety, comparative effectiveness research, and health economics and outcomes research in the areas of hematology and oncology. She is serving as a reviewer for 12 journals. Her extensive research has resulted in over 60 peer-reviewed publications.

Drug safety issues associated with cancer drugs. Epidemiology, Health economics, Outcomes research, Comparative effectiveness research, Cross-trial comparisons and statistical methods, Observational data and study methods.

Dr. Christopher V. Maani was chief of anesthesia in U.S. Army Institute of Surgical Research.

Anaesthesia, Surgical Research

Dr. Shimian Zou is the Principal Investigator of Epidemiology and Surveillance program with the American Red Cross Holland Laboratory. He received a PhD in microbiology and immunology from University of Ottawa, Canada in 1995. He received a Master’s degree in epidemiology in 1986 and completed his medical school training in 1979, both from China. He is serving as a reviewer for 5 journals. He has published over 70 scientific papers.

Epidemiology, Transmissible diseases, Blood safety, Public health.

Andreas Tiede is currently working in Hannover Medical School Under the department of Hematology & Haemostasis.

Hemophilia A
Haemophilia B
von Willebrand\'s Diseases
Hemorrhage
 

Jin Sung Lee has been working as an Assistant Professor at the University of Pittsburgh.

Medical Oncology, Hematology

Dr. Ivana Rizzuto is currently specialty trainee in obstetrics and gynaecology in the UK. She has received her MBChB in medicine at the University of Catania in Italy in 1999 with full mark. She was awarded the scholarship Barbagallo San Giorgio for her undergraduate degree thesis in 1999. She has received the Diploma of Family Planning in London in 2007. She has completed her membership exams in the UK in 2010 and she is now member of the Royal College of Obstetricians and Gynaecologist in the UK. She has 13 publications. 6 poster presentations in international congresses. 9 oral presentations in international congresses. She was awarded in 2007 the De Jode Fund (UK) to aid her oral presentation at the 36th Global Congress of Minimal Invasive Gynaecology. She is a review author with the Cochrane Gynaecological oncology group. She has reviewed articles for the Archives of Obstetrics and Gynaecology Journal, Human Reproduction Journal and European Journal of Obstetrics and Gynaecology.

Gynecological oncology (uterine/ovarian/vulva cancer), Minimal invasive surgery, Early screening for gynecological cancers, Management of ectopic pregnancies, Infertility drugs and risk of cancer.

Dr. Bea has been working as an Assistant Professor of nursing in chicago state university, USA

Functional Performance in Elderly Obese People, Lacto-ovo-vegetarians Health Education on Behavior of School Children.

Dr. Utkarsh Acharya, DO serves as a second year Internal Medicine resident and clinical instructor at The Ohio State University College of Medicine in Columbus, OH. Dr. Acharya completed his undergraduate education at Wilmington College in Wilmington, OH and pursued his medical education at Ohio University College of Osteopathic Medicine in Athens, OH where he received the Ohio University Biomedical Sciences Award for exemplary performance in the biomedical sciences. Over the course of his education, Dr. Acharya has also received recognition from prominent institutions such as the American Society for Microbiology as well as the National Institute of Health. He completed his medical internship at the University of South Florida in Tampa, FL and has a wide array of research publications ranging from general internal medicine to hematology-oncology while serving as a reviewer for several peer reviewed journals.

Hematology-Oncology

Dr. David Stroncek completed his undergraduate and medical school degrees, an internal medicine residency and a hematology/oncology fellowship at the University of Minnesota. He then joined the faculty of the University of Minnesota Medical School, Laboratory Medicine and Pathology Department as associate medical director of the blood blank. He helped establish the National Marrow Donor Program (NMDP) and was the organization’s first medical director. During his four years as medical director of the NMDP, the program coordinated their first unrelated donor transplant and subsequently increased the number of employees and marrow donations by unrelated individuals. He has served on several NMDP committees as president of the council of the NMDP and as a member of the NMDP board of directors. Dr. Stroncek came to the NIH Clinical Center Department of Transfusion Medicine (DTM) in 1996 as chief of the Laboratory Service Section. In this role, he directed the HLA and Transfusion Services Laboratories. He has published more than 170 articles in scientific journals and has written several book chapters. He has served on the editorial boards of several scientific journals.

leukocyte antibodies to transfusion reactions and advanced the understanding of the molecular basis of neutrophil-specific antigens.

Dr. Peng Qu was an assistant research professor in the department of pathology and lab medicine in Indiana university school of medicine, USA

Investigating molecular mechanism of Api6 (Apoptosis inhibitor 6) and MMP12 in modulating immunological function of MDSCs (Myeloid-derived suppressor cells), using myeloid-specific mouse model. The effects of inflammation can be shown to extend all the way back to the most primitive hematopoietic progenitors. This may have important implications for the control of inflammation in patients. Stat3 and its downstream genes serve as biomarkers for lung adenocarcinoma and COPD diagnosis and prognosis in humans. Establish in-house expertise in animal models relevant to testing efficacy and safety of those human antibodies to generate in vitro and in vivo data that support investigational new drug filings for product candidates.

BS in Pharmacy from Shanghai Medical University
MS and PhD in Clinical Pharmacy from Purdue University
Post doctoral/Clinical Pharmacology Fellowship training at the University of Chicago

Dr. Huang is currently an Assistant Professor of Medicine; Director, the Pharmacogenomics of Anticancer Agents Research (PAAR) Cell Line Core; Member, Committee on Clinical Pharmacology and Pharmacogenomics, the University of Chicago Comprehensive Cancer Center, Center for Personalized Therapeutics, Committee on Cancer Biology and Faculty Oversight Committee for Pharmacology Core facility.

Dr. Huang is a member of American Association for Cancer Research (AACR), American Society of Human Genetics (ASHG) and American Society of Clinical Pharmacology and Therapeutics (ASCPT).  She serves on the editorial board of Genomics, Proteinomics and Bioinformatics, and as a reviewer for Behavioral and Brain Functions, Clinical Pharmacology & Therapeutics, Genetic Epidemiology, Human Mutation, Pharmacogenomics, Journal of Cellular & Molecular Medicine, Pharmacogenetics & Genomics, Neoplasia, Molecular Cancer Therapeutics, Drug Metabolism and Disposition and Pharmacotherapy .

 

My lab research focuses on translational pharmacogenomic research with particular interest in the pharmacogenomics of anticancer agents. By systematically evaluating the human genomes and their relationships to drug response and toxicity, our goal is to develop clinically useful models that predict risks for adverse drug reactions and non-response prior to administration of chemotherapy.  We utilize cell lines (derived from healthy and disease individuals as well as commercially available cancer cell lines), and clinical samples to discover and functional characterize genetic variations, gene and microRNA (miRNA) expression for their role in chemotherapeutic sensitivity. 

Dr. Sadaka is certified by the American Board of Internal Medicine in Internal Medicine and Critical Care Medicine and certified by the United Council of Neurologic Subspecialties in Neurocritical care. Dr. Sadaka has assumed the medical directorship of the Neurocritical care program and the Neurologic and Trauma Intensive Care Unit at Mercy Hospital St Louis. Dr. Sadaka is a member of the Society of Critical Care Medicine and a member of the Neurocritical Care Society. Dr. Sadaka is actively involved in clinical research. He has several peer-reviewed publications, especially pertaining to neuroscience, traumatic brain injury, sepsis and the microcirculation. Dr. Sadaka also authored and co-authored multiple book chapters, especially pertaining to Sepsis, the microcirculation, neuroscience and therapeutic hypothermia. Dr. Sadaka also serves as a reviewer for several peer-reviewed journals.

Microcirculation, sepsis, Therapeutic Hypothermia, cardiac arrest and traumatic brain injury.

Education and Training:
1999, 7    M. D., Dalian Medical University, China
2002, 7    M. S., Pathology and Pathophysiology, Dalian Medical University, China
2005, 6    Ph. D., Biochemistry and Molecular Biology, Gene Research Center, Shanghai Medical College of Fudan University, China
2005, 10 – 2006,9    Postdoctoral Scholar (Research Scholar), Section of Hematology/Oncology, Department of Medicine, University of Chicago (Mentors: Drs. Janet D. Rowley and Jianjun Chen)

2006, 10 – 2007, 9    Postdoctoral fellow, Section of Hematology/Oncology, Department of Medicine, University of Chicago (Mentors: Drs. Janet D. Rowley and Jianjun Chen)

2007, 10 – 2010, 1    Postdoctoral Scholar (Research Scholar), Section of Hematology/Oncology, Department of Medicine, University of Chicago (Mentors: Drs. Janet D. Rowley and Jianjun Chen)

Academic Appointments:
2010, 2 - present
    Research Associate (Assistant Professor), Section of Hematology/Oncology, Department of Medicine, University of Chicago

As a cancer research scientist, I’m interested in and focusing on the function of microRNAs (miRNAs) and protein coding genes in acute leukemia and stem cell development. I’m currently doing research on several miRNAs and genes that play an important role in acute myeloid leukemia with different translocations such ast(8;21) orMLL associated leukemia. In particular, I am studying the function of the miRNAs which are highly or lowly expressed in leukemia, and their critical target genes in the development of leukemia, and am also investigating the relevant molecular mechanisms. My goal is to develop a deep understanding of cancer biology, especially the mechanisms leading to leukemogenesis, and to find the potential target for the clinical treatment and bring that knowledge to the benefit of patients.
 

Magali J. Fontaine MD PhD is Associate Director of the Stanford University Medical Center Transfusion Service and Assistant Director of the Stanford Blood center. She received her MD degree from the University of Paris, Rene Descartes, and her PhD in Immunology/Cell Transplantation from the University of Illinois at Chicago.  She completed her Clinical Fellowship in Transfusion Medicine at the Mayo Clinic, Rochester MN. Her research interest lies at the frontier of Transfusion Medicine and transplantation research. While her efforts in blood transfusion therapy are aimed at optimizing the quality of the blood supply chain and minimizing post transfusion adverse events, she leads national committees on developing standards for novel cellular therapies.

Blood Bank & Transfusion Medicine

Dr. Nabhani Shereen is a Senior Lecturer in Pharmacy Practice at the Kingston University School of Pharmacy in London, UK. She is board certified in Oncology Pharmacy Practice (BCOP) Completed an Oncology Pharmacy Residency at H. Lee Moffitt Cancer Centre in Florida, USA Completed a general Pharmacy practice residency at Deconess Medical Centre in Washington State, USA. She received her doctorate in Pharmacy from the Lebanese American University School of Pharmacy in 2001. She is the editorial board member of the Journal of Oncology Pharmacy Practice.

Supportive care for Cancer Patients, Role of the community pharmacist in cancer care, Psychosocial Support for Cancer patients, Oncology, CPD modules for pharmacists

Ph.D. in Health Psychology (Athens, Panteion University), M.Sc. Social exclusion and minorities (Panteion University), Social Administration - Management of Health Services (Athens, National School of Public Administration), B.Sc. (Psychology) (Panteion University), B.Sc. (Social Work) (Technological Educational Institute of Athens)

My research interests within the field of behavioral medicine/health psychology are focused on heath - related quality of life, mental health (depression, anxiety), health locus of control as well as medication compliance in chronic illness with particular reference to kidney disease, renal dialysis and transplantation. Most of my work centers on delineating psychological processes that underline patients’ outcomes and physical disease course.

•    Psychosocial processes, outcomes and quality of life in chronicillness with particular emphasis on chronic kidney disease, dialysis and renal transplantation
•    Self management interventions for patients with chronic illness
•    Palliative care in severe chronic disease
 

Dr Z.A.Jeremiah is an Assistant Professor of Haematology and Blood Transfusion Sciences at the Niger Delta University, Wilberforce Island, Nigeria. He holds a Ph.D in Haematology and Blood Group Serology. He is conscientious and hardworking and has been involved in research activities since 2002. His scholarly accomplishment includes fifty five (55) peer reviewed research publications.

Immunohaematology, Blood Transfusion, General Haematology Practice, Platelet glycoproteins.